by Vora Corporate Finance | Sep 9, 2024 | Insights
The BSE Sensex closed at 81,455 up by 3.07% and the Nifty 50 closed at 24,857 up by 3.53% in July 2024 led as the market’s focus shifted to the Federal Reserve’s rate decision and commentary on monetary policy despite the volatility experienced after the budget on the...
by Vora Corporate Finance | Aug 22, 2024 | Insights, Merger & Acquisitions
Transaction: Mankind Pharma Limited is to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV) from PE fund Advent International for an EV of Rs. 13,630 Crores. The transaction was done at EV/Ebitda multiple of around 22x to 23x. The deal will be through...
by Vora Corporate Finance | Aug 22, 2024 | Insights
Union Budget 2024-25: Finance Minister (Nirmala Sitharaman) presented the first budget of BJP led NDA government’s third term and as per expectation continued the sustainable economic development goals in pursuit of ‘Viksit Bharat’. Agriculture: The government will...
by Vora Corporate Finance | Jul 8, 2024 | Insights, Private Equity & IPO
Transaction: Morgan Stanley PE fund, invested INR 500 Crores for a minority stake of 23% stake in Hyderabad Institute of Oncology Private Limited (Omega Hospitals), valuing the hospital chain at more than Rs. 2100 Crores. It will support the ambitious plan of Omega...
by Vora Corporate Finance | Jul 8, 2024 | Insights, Merger & Acquisitions
Transaction: Adani owned Ambuja Cements Limited enters into binding agreement for the acquisition of Hyderabad-based Penna Cement Industries Limited (PCIL) at an EV of Rs. 10,422 Crore. Ambuja will acquire 100% shares of PCIL from its existing promoter group P Pratap...
